Literature DB >> 19840554

Innate and adaptive autoimmunity directed to the central nervous system.

Roopa Bhat1, Lawrence Steinman.   

Abstract

The immune system has two major components, an innate arm and an adaptive arm. Certain autoimmune diseases of the brain represent examples of disorders where one of these constituents plays a major role. Some rare autoimmune diseases involve activation of the innate arm and include chronic infantile neurologic, cutaneous, articular (CINCA) syndrome. In contrast, adaptive immunity is prominent in multiple sclerosis, neuromyelitis optica, and the paraneoplastic syndromes where highly specific T cell responses and antibodies mediate these diseases. Studies of autoimmune brain disorders have aided in the elucidation of distinct neuronal roles played by key molecules already well known to immunologists (e.g., complement and components of the major histocompatibility complex). In parallel, molecules known to neurobiology and sensory physiology, including toll-like receptors, gamma amino butyric acid and the lens protein alpha B crystallin, have intriguing and distinct functions in the immune system, where they modulate autoimmunity directed to the brain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19840554     DOI: 10.1016/j.neuron.2009.09.015

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  63 in total

1.  Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase.

Authors:  Sourojit Bhowmick; Robert B Clark; Stefan Brocke; Robert E Cone
Journal:  Int Immunol       Date:  2011-01-27       Impact factor: 4.823

Review 2.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

Review 3.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

4.  Induction of recombinase activity in peripheral T cells in multiple sclerosis.

Authors:  E M Kuklina; I V Nekrasova; O L Schuklina; T V Baydina; I Yu Danchenko
Journal:  Dokl Biol Sci       Date:  2014-01-03

5.  Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.

Authors:  Khrishen Cunnusamy; Ethan J Baughman; Jorge Franco; Sterling B Ortega; Sushmita Sinha; Parul Chaudhary; Benjamin M Greenberg; Elliot M Frohman; Nitin J Karandikar
Journal:  Clin Immunol       Date:  2014-03-20       Impact factor: 3.969

6.  Oligodendrocytes Death Induced Sensorimotor and Cognitive Deficit in N-nitro-L-arginine methyl Rat Model of Pre-eclampsia.

Authors:  Olayemi K Ijomone; Philemon Dauda Shallie; Thajasvarie Naicker
Journal:  Neurochem Res       Date:  2020-01-25       Impact factor: 3.996

7.  Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.

Authors:  Yudong Liu; Andrew T Holdbrooks; Patrizia De Sarno; Amber L Rowse; Lora L Yanagisawa; Braden C McFarland; Laurie E Harrington; Chander Raman; Steffanie Sabbaj; Etty N Benveniste; Hongwei Qin
Journal:  J Immunol       Date:  2013-12-09       Impact factor: 5.422

Review 8.  Commensal regulation of T cell survival through Erdr1.

Authors:  Allison M Weis; Raymond Soto; June L Round
Journal:  Gut Microbes       Date:  2018-04-11

9.  Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin.

Authors:  Wei Shao; Shu-zhen Zhang; Mi Tang; Xin-hua Zhang; Zheng Zhou; Yan-qing Yin; Qin-bo Zhou; Yuan-yuan Huang; Ying-jun Liu; Eric Wawrousek; Teng Chen; Sheng-bin Li; Ming Xu; Jiang-ning Zhou; Gang Hu; Jia-wei Zhou
Journal:  Nature       Date:  2012-12-16       Impact factor: 49.962

Review 10.  Anti-angiogenic gene therapy in the treatment of malignant gliomas.

Authors:  NaTosha N Gatson; E Antonio Chiocca; Balveen Kaur
Journal:  Neurosci Lett       Date:  2012-08-10       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.